4//SEC Filing
AGIOS PHARMACEUTICALS INC 4
Accession 0001209191-16-089018
$AGIOCIK 0001439222operating
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:20 PM ET
Size
11.4 KB
Accession
0001209191-16-089018
Insider Transaction Report
Form 4
Higgons John Duncan
Chief Operating Officer10% Owner
Transactions
- Exercise/Conversion
Common stock
2016-01-04$2.34/sh+57,024$133,436→ 118,859 total - Exercise/Conversion
Stock option (right to buy)
2016-01-04−1,975→ 180,113 totalExercise: $31.64Exp: 2024-03-04→ Common stock (1,975 underlying) - Exercise/Conversion
Common stock
2016-01-04$31.64/sh+1,975$62,489→ 120,834 total - Exercise/Conversion
Stock option (right to buy)
2016-01-04−57,024→ 182,088 totalExercise: $2.34Exp: 2022-04-05→ Common stock (57,024 underlying)
Footnotes (2)
- [F1]This option was granted on April 6, 2012 for the purchase of 63,636 shares of common stock. The option vests as to 25% upon the achievement of a performance milestone, as to an additional 50% upon the achievement of a second performance milestone, and as to the remaining 25% on the first anniversary of the first date that both performance milestones were achieved. The performance criteria for the first performance milestone were met on March 18, 2013. The performance criteria for the second performance milestone were met on April 4, 2014, and the remaining shares vested on April 4, 2015.
- [F2]This option was granted on March 5, 2014. The shares underlying this option vest as to 25% of the underlying shares on March 5, 2015, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
AGIOS PHARMACEUTICALS INC
CIK 0001439222
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001439222
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 5:20 PM ET
- Size
- 11.4 KB